Onset of Action of Selected Second-Generation Antipsychotics (Pines)–A Systematic Review and Meta-Analyses

Recommendations for duration of treatment with antipsychotics before considering a switch vary from 2 to 8 weeks, although several studies suggest a rapid onset of action. The objective of this review was to estimate time to onset of action and time to maximum antipsychotic effect of asenapine, olan...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Rikke Meyer, Kenneth Skov, Inderjeet Kaur Dhillon, Emilie Olsson, Niels Albert Graudal, Lone Baandrup, Gesche Jürgens
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	antipsychotic action antipsychotic effect antipsychotic agents pines psychopharmacology schizophrenia
Online Access:	https://www.mdpi.com/2227-9059/11/1/82

Similar Items

Considerations for Augmenting Aripiprazole Long-Acting Injectables with Other Antipsychotics: A Mini-Review
by: Jonathan Shaw, et al.
Published: (2025-08-01)

Pathophysiology and management of risperidone-induced sialorrhea: case report
by: Tyler Torrico, et al.
Published: (2023-07-01)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01)

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
by: Hikaru Hori, et al.
Published: (2022-05-01)

Study of factors associated with obesity in patients using antipsychotics in schizophrenia
by: Vishalakshi Patnam, et al.
Published: (2024-12-01)

The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review
by: Petru Fabian Lungu, et al.
Published: (2024-04-01)

A comparison of depot and oral atypical antipsychotics in terms of metabolic syndrome markers
by: Demet Sağlam Aykut, et al.
Published: (2018-07-01)

Risk factors for pneumonia in patients with schizophrenia
by: Takahiro Haga, et al.
Published: (2018-12-01)

Unlocking the molecular mechanisms of antipsychotics – a new frontier for discovery
by: Heather Bowling, et al.
Published: (2016-07-01)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
by: Hiroyuki Kamei
Published: (2022-11-01)

Antipsychotics for elderly with psychosis: Deprescribe or continue?
by: P. Mohr
Published: (2021-04-01)

Assessment of hospitalizations in schizophrenia patients treated with paliperidone 1-monthly (PP1M), paliperidone 3-monthly (PP3M), aripiprazole once-monthly (AOM) and other oral antipsychotics (OAP) in clinical practice
by: L. Gutiérrez Rojas, et al.
Published: (2021-04-01)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-08-01)

Hormonal alterations due to antipsychotic-related hyperprolactinemia
by: A.L. Montejo, et al.
Published: (2022-06-01)

Clozapine: A special case of an atypical antipsychotic
by: Elina Marinho
Published: (2024-04-01)

A single blind comparative clinical study of the effects of chlorpromazine and risperidone on positive and negative symptoms in patients of schizophrenia
by: Amrita Prakash Singam, et al.
Published: (2011-01-01)

Correlations between receptor occupancy change and mental state in patients using long-acting injectable antipsychotics: MIDILIA pilot study
by: James R. O’Neill, et al.
Published: (2025-09-01)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
by: Olga Płaza, et al.
Published: (2022-12-01)

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
by: M. Lähteenvuo, et al.
Published: (2021-04-01)

The Novel Antipsychotic Lumateperone (Iti-007) in the Treatment of Schizophrenia: A Systematic Review
by: Giulio Longo, et al.
Published: (2023-11-01)

Pattern of Antipsychotics in Schizophrenia Outpatients at Lampung Province Mental Hospital
by: Isnenia Isnenia
Published: (2022-03-01)

The treatment characteristics of oral antipsychotics in treatment of adolescents with schizophrenia in China
by: Huaning Wang, et al.
Published: (2025-07-01)

Combination treatment with second generation antipsychotics other than clozapine
by: C. Schmidt-Kraepelin
Published: (2021-04-01)

Is there constitutional and morphological predisposition to akathisia in schizophrenic patients receiving antipsychotic therapy?
by: A. A. Goncharova, et al.
Published: (2020-01-01)

Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia
by: E. G. Kornetova, et al.
Published: (2019-10-01)

Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
by: O. Vasiliu
Published: (2022-06-01)

Evaluation of naltrexone augmentation to the antipsychotic drugs on positive and negative symptoms of schizophrenia
by: Javad Setareh, et al.
Published: (2008-01-01)

Prescription pattern of antipsychotics in patients with schizophrenia: An observational study at a tertiary care hospital in rural Karnataka
by: Nameerah Javed, et al.
Published: (2024-12-01)

Transitions of care: Assessment of adherence to long-acting injectable antipsychotic treatment following discharge from inpatient psychiatry
by: Charnae Ross, PharmD, MSHA, BCSCP, et al.
Published: (2025-02-01)

Efficacy and Tolerance of Antipsychotics Used for the Treatment of Patients Newly Diagnosed with Schizophrenia: A Systematic Review and Meta-Analysis
by: Zina Sherzad Qadir, et al.
Published: (2023-11-01)

Effectiveness of oral versus long-acting antipsychotic treatment early-phase schizophrenia patients: an open-label randomized trial
by: I. Winter, et al.
Published: (2022-06-01)

Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
by: Mulualem Kelebie, et al.
Published: (2025-02-01)

Atypical antipsychotics in the treatment of schizophrenia
by: Swiss Medical Weekly
Published: (2003-02-01)

The Effect of Menopause on Antipsychotic Response
by: Alexandre González-Rodríguez, et al.
Published: (2022-10-01)

Weight Gain, Mental Symptoms and Self-Esteem in Patients with Schizophrenia
by: Sevde Öner, et al.
Published: (2022-12-01)

The antipsychotics functional index (AFI) in schizophrenia
by: Gabriel-Cristian Marinescu, et al.
Published: (2025-07-01)

Atypical Antipsychotics Induced Metabolic Syndrome
by: Aysegul Demirel, et al.
Published: (2015-03-01)

Retrospective analysis of antipsychotic prescription models in correlation with symptoms of residual schizophrenia. Part 1
by: D. N. Safonov
Published: (2020-08-01)

Differential Treatment Responses in Pakistani Schizophrenia Samples: Correlation with Sociodemographic Parameters, Drug Addiction, Attitude to the Treatment and Antipsychotic Agents
by: Umme Habiba, et al.
Published: (2023-02-01)

Treatment of antipsychotic-induced parkinsonism in schizophrenic patients
by: E. E. Vaiman, et al.
Published: (2021-08-01)